Last update:
Medications news
Medications
Drugs approved for treating pain may also reduce bone cancer growth
Peripheral afferent neurons—nerves that send signals from all areas of the body to the central nervous system (brain and spinal cord)—are known to infiltrate and grow within malignant bone tumors called osteosarcomas, ...
11 hours ago
0
28
Medications
FDA approves Tezspire for chronic rhinosinusitis with nasal polyps
The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adult and pediatric patients ...
8 hours ago
0
0
Whole tablets may be safer than crushed ones for patients with poststroke swallowing disorders
For decades, stroke patients with swallowing difficulties have routinely received crushed tablets to reduce the risk of aspiration. New clinical data now challenge this practice. A study using endoscopic swallowing diagnostics ...
11 hours ago
0
0
Efforts to promote safer opioid prescribing in Canada appear to be having an effect
Efforts to promote safer opioid prescribing in Canada appear to be having an effect, as new research in the Canadian Medical Association Journal shows a decrease in opioid dispensing between 2018 and 2022.
Oct 27, 2025
0
0
Experimental inhibitor reduces cell death in models of life-threatening skin reactions
A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous adverse reactions such as Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
Oct 24, 2025
0
0
New drug tested in mice could fill treatment void for most severe heart attack patients
A new drug being trialed in heart attack patients could reprogram the immune system to prevent inflammation and heart damage following severe heart attacks, and promote repair. This could be a game-changer in treating the ...
Oct 24, 2025
0
1
Psilocybin + mindfulness show promise for health care worker depression
Front-line health care workers struggling with depression after the COVID-19 pandemic experienced significant relief from a treatment combining psilocybin group therapy with mindfulness training, according to a new study ...
Oct 23, 2025
0
20
Parent opioid prescriptions linked to teen and young adult opioid use
If a parent has persistent opioid prescriptions, their adolescent or young adult offspring has more than double the risk of persistent opioid use, according to a new study published in PLOS Medicine by Anna Marcuzzi of the ...
Oct 23, 2025
0
0
Experimental targeted therapy shows promise for histiocytosis, a rare blood cancer
The first time Joey Carlsen Martinez came to Memorial Sloan Kettering Cancer Center (MSK), he was in terrible shape. He had a rare blood cancer called Erdheim-Chester disease, and his symptoms included crushing fatigue, severe ...
Oct 23, 2025
0
0
Novel drug combinations pave the way for personalized leukemia therapies
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a review on BH3 mimetics—a new class of drugs that are reshaping the treatment landscape for acute myeloid ...
Oct 23, 2025
0
0
New drug study shows improved survival for early breast cancer
Mayo Clinic researchers collaborated on a new study led by Eli Lilly showing that the drug abemaciclib improves survival for people with high-risk, early-stage breast cancer.
Oct 23, 2025
0
0
Amid the noise about Tylenol, there's a real risk—an overdose
While news feeds and social media are abuzz with unproven claims about links between acetaminophen and autism in children, there are well-established concerns about the harmful effects of an overdose of the over-the-counter ...
Oct 23, 2025
0
0
Antidepressants show promise for alleviating jaw pain
Certain antidepressants can help alleviate chronic jaw pain caused by temporomandibular disorders (TMDs), according to a research review by a team of researchers with expertise in dentistry and pharmacy published in the Journal ...
Oct 23, 2025
0
0
No benefit from ketamine for patients hospitalized with depression, clinical trial reports
Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have revealed no extra benefit from ketamine when added to standard care for people admitted to hospital ...
Oct 22, 2025
0
0
Cancer drug quality in Africa is a worry, four-country study finds
The number of people receiving treatment for cancer has risen dramatically in the last decade in many African countries. For example, 10 years ago in Ethiopia and Kenya, cancer care was available to only a few thousand patients ...
Oct 22, 2025
0
0
Stopping long-term opioid treatment unlikely to increase suicide risk, major study finds
People on long-term opioid treatment can be reassured that stopping these medicines is not likely to increase their risk of suicide or fatal overdose, thanks to a major new study from the National Drug and Alcohol Research ...
Oct 22, 2025
0
0
Antidepressants vary widely in their physical side effects, highlighting the need for personalized prescribing
Antidepressants can differ widely in how they physically affect the body, including around a 4 kg difference in weight change between certain drugs (approximately 2.5 kg weight loss from agomelatine and 2 kg weight gain from ...
Oct 21, 2025
0
0
FDA to fast-track nine experimental drugs under new Trump program
The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs.
Oct 21, 2025
0
1
Oral drug demonstrates promising anti-tumor activity in patients with advanced lung cancer
The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant non-small cell lung cancer (NSCLC), according to data from a trial led by researchers at The University ...
Oct 20, 2025
0
97
Resistance to epilepsy treatments may wane over time, study suggests
About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly to available therapies. Yet they too may eventually see improvement, if not total relief, from their ...
Oct 20, 2025
0
0
New weight loss pill aims to bridge gap in obesity treatments
An innovative new pill could soon offer a new and affordable weight management treatment, following a successful clinical trial involving University of Bristol researchers. The results are published in a paper titled "A randomized, ...
Oct 20, 2025
0
0
Mortality down with GLP-1 receptor agonist use in T2D, especially in those with OSA
Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially those also diagnosed with obstructive sleep apnea (OSA), ...
Oct 20, 2025
0
0
Open heart surgery: Clinicians don't know the best way to support patients with post-operative pain, study finds
Every year, more than 12,000 Australians undergo open heart surgery—an hours-long medical procedure during which surgeons go inside the chest cavity and repair faulty heart valves or bypass blocked cardiac arteries.
Oct 20, 2025
0
0
SGLT2 inhibitors may slow nodule growth in pulmonary malignancies
For patients with diabetes and early-stage pulmonary malignancies, administration of a sodium-glucose cotransporter 2 inhibitor (SGLT2-i) slows nodule growth and reduces the need for surgical interventions, according to a ...
Oct 20, 2025
0
0
NHS policies to improve care for people taking multiple medicines may not be effective
Current NHS policies designed to improve care for people taking multiple medicines may not be effective, according to new research.
Oct 20, 2025
0
0
